In our previous study, we identified SLC25A22, which encodes a mitochondrial glutamate transporter, as a novel oncogene essential for the viability of CRC cell lines with simultaneous mutations in APC or CTNNB1 and KRAS [7]. This evidence concerns the gene KRAS and colorectal carcinoma.